8-K - Moderna, Inc. (0001682852) (Filer)
Published . Updated .
Key takeaways
- 8-K - Moderna filed an 8-K with the SEC on Nov 6 (a notice of a material company event).
- Exposed: MRNA
- Market reaction: price tracking starts with the next trading session.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Moderna filed an 8-K with the SEC on Nov 6 (a notice of a material company event).
Directly affected
- MRNA Moderna+25.4% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Moderna belongs to, so it often moves with news about it.
- AMGN Amgen+17.8% 30d
Amgen is a peer of Moderna in biological products, (no diagnostic substances); rivals often move on the same news.
- GILD Gilead Sciences+16.3% 30d
Gilead Sciences is a peer of Moderna in biological products, (no diagnostic substances); rivals often move on the same news.
- ARGX argenx SE-17.3% 13d
argenx SE is a peer of Moderna in biological products, (no diagnostic substances); rivals often move on the same news.
- RVMD Revolution Medicines
Revolution Medicines is a peer of Moderna in biological products, (no diagnostic substances); rivals often move on the same news.
- BIIB Biogen+18.0% 18d
Biogen is a peer of Moderna in biological products, (no diagnostic substances); rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| MRNA | -8.19% | -5.38% | base | after close | after close | after close | after close |
| XLV | -0.05% | -0.52% | base | after close | after close | after close | after close |
| AMGN | +1.22% | +0.14% | base | after close | after close | after close | after close |
| GILD | +2.05% | -0.01% | base | after close | after close | after close | after close |
| ARGX | -0.15% | +0.79% | base | after close | after close | after close | after close |
| RVMD | +7.60% | +9.18% | base | after close | after close | after close | after close |
| BIIB | +3.96% | +2.07% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-06 AccNo: 0001682852-26-000194 Size: 332 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Moderna (MRNA)
Across 4 earlier stories, Moderna (MRNA) the next day averaged +11.35%. The largest gain was +16.98% and the largest drop was +5.69%, from 4 prices.
| Company | When | Average | Largest gain | Largest drop | Prices |
|---|---|---|---|---|---|
| Moderna (MRNA) | the next day | +11.35% | +16.98% | +5.69% | 4 |
| Moderna (MRNA) | three days later | -7.30% | -7.30% | -7.30% | 2 |
Moderna (MRNA) since “8-K - Moderna, Inc. (0001682852) (Filer),” compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| AMGN | three days earlier | +0.14% | final price |
| AMGN | five days earlier | +1.22% | final price |
| ARGX | three days earlier | +0.79% | final price |
| ARGX | five days earlier | -0.15% | final price |
| BIIB | three days earlier | +2.07% | final price |
| BIIB | five days earlier | +3.96% | final price |
| GILD | three days earlier | -0.01% | final price |
| GILD | five days earlier | +2.05% | final price |
| Moderna (MRNA) | three days earlier | -5.38% | final price |
| Moderna (MRNA) | five days earlier | -8.19% | final price |
| RVMD | three days earlier | +9.18% | final price |
| RVMD | five days earlier | +7.60% | final price |
| XLV | three days earlier | -0.52% | final price |
| XLV | five days earlier | -0.05% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Maria Elvira Salazar sold Moderna (MRNA), worth $1,001 - $15,000 on 24 Sep 2026. That is 43 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Moderna (MRNA) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 63 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Moderna (MRNA), worth $1,001 - $15,000 on 28 Aug 2026. That is 70 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. David J. Taylor bought Amgen (AMGN), worth $1,001 - $15,000 on 22 Sep 2026. That is 45 days before publication. Filed 1 Oct 2026. View the filing.
- Rep. David J. Taylor sold Amgen (AMGN), worth $1,001 - $15,000 on 26 Aug 2026. That is 72 days before publication. Filed 5 Sep 2026. View the filing.
- Sen. Sheldon Whitehouse sold Amgen (AMGN) (held by a spouse), worth $1,001 - $15,000 on 12 Aug 2026. That is 86 days before publication. Filed 2 Sep 2026. View the filing.
- Rep. Rohit Khanna sold Gilead Sciences (GILD) (held by a dependent child), worth $1,001 - $15,000 on 10 Aug 2026. That is 88 days before publication. Filed 4 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Biogen (BIIB), worth $1,001 - $15,000 on 24 Sep 2026. That is 43 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Biogen (BIIB) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 63 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Kevin Hern sold Biogen (BIIB), worth $1,001 - $15,000 on 18 Aug 2026. That is 80 days before publication. Filed 1 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - Moderna, Inc. (0001682852) (Filer)”
Companies carried with this story
- MRNA Moderna
Moderna (MRNA) is linked, with no stored direction, high confidence in the 6 Nov 2026 story “8-K - Moderna, Inc. (0001682852) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> MRNA
How “8-K - Moderna, Inc. (0001682852) (Filer)” reaches Moderna (MRNA)
“8-K - Moderna, Inc. (0001682852) (Filer)” (6 Nov 2026) reaches Moderna (MRNA) through this story.
Moderna (MRNA) is on the page because SEC 8-K filing -> direct issuer disclosure -> MRNA
Dates in the story, and the Moderna (MRNA) price range
MRNA traded between 179.60 and 254.43 across 20 sessions. The latest close on file is 228.39.
What the saved facts support for Moderna (MRNA)
14 out of 100
“8-K - Moderna, Inc. (0001682852) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.